Categories: Market News

ExxonMobil (XOM) Q4 profit declines 5% but beats estimates

ExxonMobil (NYSE: XOM) reported a 5% decline in earnings for the fourth quarter of 2019 due to weakness in crude oil demand as well as short-term supply length in the downstream and chemical businesses. However, the results exceeded analysts’ expectations.

Net income plunged by 5% to $5.69 billion or $1.33 per share. Revenue dropped by 7% to $67.17 billion. Analysts had expected EPS of $0.43 on revenue of $64.17 billion for the fourth quarter.

Oil-equivalent production was in line with last year at 4 million barrels per day with a 4% increase in liquids offset by a 5% decrease in gas. Excluding entitlement effects and divestments, liquids production increased 2% driven by Permian Basin growth, while natural gas volumes decreased 4%.

In upstream, average crude and natural gas realizations were essentially in line with last quarter. Liquid volumes rose 2% on growth and lower scheduled maintenance. Natural gas volumes increased 5% driven by seasonal demand. Permian unconventional development continued with production up 54% from last year.

In downstream, industry fuel margins were significantly lower than third-quarter, reflecting seasonally lower demand and increased supply from reduced industry maintenance. In chemical, margins weakened further from already depressed levels with supply length from recent industry capacity additions and higher feed costs.

Read: FuelCell Energy Q4 earnings review

ExxonMobil said that oil production started from the Liza field offshore Guyana, less than five years after the first discovery of hydrocarbons, well ahead of the industry average. Gross production from the Liza phase 1 development, located in the Stabroek block, is expected to reach a capacity of 120,000 gross barrels of oil per day in the coming months.

The company closed the previously announced sale of its non-operated upstream assets in Norway to Var Energi AS for $4.5 billion as part of its plans to divest about $15 billion in non-strategic assets by 2021. The corporation’s fourth-quarter earnings include a $3.7 billion gain on the sale.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Share
Published by

Recent Posts

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

6 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

22 minutes ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

29 minutes ago

Harley-Davidson Q4 2025 Results Reflect Margin Pressure

Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…

40 minutes ago

KO Earnings: Key quarterly highlights from Coca-Cola’s Q4 2025 financial results

The Coca-Cola Company (NYSE: KO) reported its fourth quarter 2025 earnings results today. Net revenues…

54 minutes ago

KT Corp. Annual Operating Profit Surges 205% as AI and Real Estate Drive Growth

The South Korean telecommunications provider reported a significant increase in annual profit for 2025, supported…

1 hour ago